Biogen stock sentiment

BIIB
NASDAQDrug Manufacturers - GeneralData as of Nov 06, 2026

Over the past week, Biogen (BIIB) logged 28 mentions across Reddit, X and News. The read is an Adanos Hold. The crowd average is 27% bullish. X runs 38% bullish while News sits at 15%. Wall Street is more constructive, with 25 of 36 analysts rating BIIB a buy. BIIB does not read clearly more bullish or bearish than usual this week. Its Adanos Score is 57.9 out of 100, a Hold.

Adanos signal

Hold57.9

Confidence low · Sources 2 / 4

Avg buzz

39.3out of 100

28.2 to 56.9 over the last 7 sessions

Crowd average

27%Spread 23 pts

5 of 7 sessions leaned bullish

Mentions, last 7 days

28

  • News20↑
  • X8↓
  • Reddit0→
  • YouTubeComing soon

Biogen (BIIB) buzz score vs. EOD price

BuzzEOD closeVolumeBullish, neutral, bearish
$248.35+10.0% over 21 sessions
Oct 9Nov 6

Biogen (BIIB) buzz ended the 30 days at 31.9 while the price drifted up 10.0% across the period. Average daily volume over the 21 sessions is 1.3M shares. Updated Nov 07, 2026. Over the last 7 sessions, BIIB held roughly flat. Buzz in those sessions averaged 39.8 and was variable, swinging between 28.2 and 56.9. Recent volume is in line with the 30-day average. Daily crowd sentiment leaned bullish on 16 of the 21 days with directional mentions.

Biogen (BIIB) at a glance

Adanos signal
Hold
Analyst consensus
Strong Buy (25 / 10 / 1)
Crowd average (7d)
27%
Avg price target
$264.82
Most bullish source
X, 38%
Most bearish source
News, 15%
Sentiment spread
23 pts
Mentions (7d)
28
Market cap
$36.06B
P/E · Forward P/E
105.6 · 16.5
EPS · Beta
$2.31 · 0.1
Revenue (TTM)
$10.3B · 3% margin
Industry
Drug Manufacturers - General
Exchange
NASDAQ
21-session range
$225.71 to $254.46
Avg daily volume
1.3M

Why BIIB reads Hold

Score parts, 7 days

BIIB scores 57.9 out of 100. A Buy needs 70 or more. Reddit is not counted this week. It has no bullish and bearish shares. Confidence is low. 28 mentions and trades is under the 100 that medium needs.

X+4.0

Clearly above usual. 38% bullish minus 0% bearish is a lean of +38. The usual lean is +5. Counted at 28.6%, that is +9.4 against usual, at weight 0.95.

News−0.3

Below usual. 15% bullish minus 5% bearish is a lean of +10. The usual lean is +11. Counted at 50.0%, that is −0.5 against usual, at weight 1.32.

Weighted lean
+3.7
Agreement 0.86
× 0.95
2 sources
× 0.95
Buzz 39
× 0.90
Total
+3.0
Adanos Score, 0 to 100
57.9

Usual levels as of Oct 28, 2026. The scale is 50 + 50 × tanh(total ÷ 18.9), so a total of +8 lands at 70 and −8 at 30. Figures are rounded. The score uses the exact values.

Wall Street vs the crowd on BIIB

Wall Street’s 69% buy share sits next to a crowd that ranges from News at 15% to X at 38%.

Analyst ratings

Strong Buy36 analysts · 69% buy share
25 Buy10 Hold1 Sell

+6.6% from the last close to the average target

Last close $248.35Avg target $264.82

36 analysts cover BIIB with a Strong Buy consensus. 25 rate it a buy and 1 a sell. Their average 12-month target is $264.82.

Who is bullish on BIIB

Crowd average 27%
Wall St 42 pts 69%
X 38%
News 15%
0%50%100%
Above its usual leanBelow its usual lean

Analysts sit 42 points above the crowd average of 27%. Inside the crowd, X reads 38% bullish and News 15%, a 23-point spread.

How each source saw BIIB this week

Buzz, bullish share, mentions and trades cover the last 7 days. Subreddit, publisher and trader counts, the top post and the top story cover 30 days.

RedditStableReddit API
Buzz
-
Bullish
-
Mentions
0

6 subreddits in 30 days

r/ValueInvesting
2 BIIB mentions in 30 days, more than any other subreddit.
Neutral
XFallingX API
Buzz
38.5
Bullish
38%
Mentions
8
Bullish 38%Neutral 62%Bearish 0%

8 tweets · 7-day sentiment +0.2

@buysidebioTop post, 30 days
“7. Biogen reversed its stage preference within eight months. In early 2026 it wanted Phase 3 or launched assets up to about $5–6B; now it “…”
Bullish 0.66
NewsRisingNews API
Buzz
40.1
Bullish
15%
Mentions
20
Bullish 15%Neutral 80%Bearish 5%

25 publishers in 30 days · 7-day sentiment +0.1

BenzingaTop story, 30 days
“Rep. Maria Elvira Salazar Has Bought Up to $60K Worth Of NVIDIA Stock: Here’s What You Should Know An official report on November 5, 2026 r…” MarketBeat and Yahoo Finance lead the coverage.
Neutral 0.01

BIIB in its industry

Drug Manufacturers - General · 13 most discussed, 7 days
Closest readings to BIIBTile size: mentions

Explore nearby tickers

  1. BGSB&G Foods IncHold13% bullish
  2. BHEBenchmark Electronics IncBuy73% bullish
  3. BIAFbioAffinity Technologies, Inc.Hold25% bullish
  4. BIDUBaidu IncHold25% bullish
  5. BIIBBiogenHold27% bullish
  6. BILIBilibili IncBuy55% bullish
  7. BIOBio-Rad Laboratories Inc - Class AHold7% bullish
  8. BIRDAllbirds Inc Class ABuy65% bullish
  9. BIRKBirkenstock Holding PlcHold6% bullish

Biogen (BIIB) stock sentiment FAQ

Is Biogen (BIIB) a buy or sell right now?

Based on aggregated sentiment from X and News, Biogen (BIIB) carries an Adanos hold signal with an Adanos Score of 57.9 out of 100. Confidence is low. 28 mentions and trades is under the 100 that medium needs. The crowd average reads 27% bullish across 2 active sources. Over the last 7 days those sources carry 28 mentions. This is a sentiment-based reading, not financial advice.

What does Reddit say about BIIB stock?

Reddit has no mentions of Biogen (BIIB) over the last 7 days. Over 30 days the discussion spans 6 subreddits.

Is Biogen (BIIB) bullish or bearish right now?

Biogen (BIIB) does not read clearly more bullish or bearish than usual this week, with an Adanos Score of 57.9 out of 100. In plain shares the crowd average is 27% bullish across 2 tracked sources over the last 7 days. The two ends of the range are X at 38% bullish and News at 15%, a 23-point spread. On Wall Street, 25 of 36 analysts rate BIIB a buy.

What do analysts say about Biogen (BIIB)?

Of the 36 analysts covering Biogen (BIIB), 25 rate it a buy, 10 a hold and 1 a sell, for a strong buy consensus. The average price target is $264.82. That puts Wall Street ahead of the crowd average of 27% bullish.

What is the sentiment on BIIB stock?

Biogen (BIIB)'s crowd average is 27% bullish. X reads 38% bullish and News is the most negative at 15% bullish. X reads clearly more bullish than usual. News reads more bearish than usual. Confidence is low. 28 mentions and trades is under the 100 that medium needs.

Why does BIIB carry a hold signal right now?

BIIB scores 57.9 out of 100. A Buy needs 70 or more. Reddit is not counted this week. It has no bullish and bearish shares. Confidence is low. 28 mentions and trades is under the 100 that medium needs. X reads clearly more bullish than usual. News reads more bearish than usual.

What is driving Biogen (BIIB) sentiment right now?

News is the dominant discussion channel with 20 mentions (71% of all mentions). X adds 8 mentions. The crowd average is 27% bullish, while News is the only source with rising 3-day activity. X reads clearly more bullish than usual. News reads more bearish than usual.

What does the Adanos hold signal mean for Biogen (BIIB)?

Each source's lean is its bullish share minus its bearish share. The Adanos Score compares it with that source's usual lean and weighs busier sources more. It runs from 0 to 100 with 50 as neutral. 70 or more reads Buy and 30 or less reads Sell. Everything between is Hold. Under 10 mentions and trades a stock stays at Hold. BIIB scores 57.9 out of 100 this week, so it reads Hold. It is a research shortcut, not financial advice.

How fresh is this BIIB sentiment data?

Adanos rebuilds the BIIB page once a week. When someone opens it while its sentiment is more than 24 hours old, a background update fetches fresh Reddit, X, News and Polymarket readings and the latest daily prices. The next visit shows them. Company facts and analyst ratings update with the weekly rebuild. The sentiment figures cover the last 7 days.

Explore more stocks

Build on this data

  • Finance Sentiment CLIQuery sentiment for BIIB and 50,000+ tickers from your terminal. Filter by source, date range and minimum buzz.View CLI
  • Website widgetsEmbed live BIIB sentiment on your own site with drop-in web components.View widgets